|
|
Thomson Financial Business Description:
| The Group's principal activity is to develop, manufacture and commercialize prophylactic and therapeutic vaccines against infectious diseases. The Group also develops own pharmaceutical product pipeline and commercializes its discoveries, which result from proprietary research and development programs to external partners. The Group's other related business activities include product research and development, regulatory, clinical, administrative and corporate development activities, and establishing production capabilities for clinical trials. |
|
Alacra Alerts:
|
Receive alerts on the latest reports on Intercell AG
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|